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We proposed a model in which myocardial hypoxia triggers the apoptosis-dependent remodeling of the avian outflow tract (OFT) in the
transition of the embryo to a dual circulation. In this study, we examined hypoxia-dependent signaling in cardiomyocyte apoptosis and
outflow tract remodeling. The hypoxia-inducible transcription factor HIF-1a was specifically present in the nuclei of OFT cardiomyocytes
from stages 25–32, the period of hypoxia-dependent OFT remodeling. HIF-1a expression was sensitive to changes in ambient oxygen
concentrations, while its dimerization partner HIF-1h was constitutively expressed. There was not a simple relationship between HIF-1a
expression and apoptosis. Apoptotic cardiomyocytes were detected in HIF-1a-positive and -negative regions, and a hypoxic stimulus
sufficient to induce nuclear accumulation of HIF-1a did not induce cardiomyocyte apoptosis. The hypoxia-dependent expression of the
vascular endothelial growth factor receptor (VEGFR2) in the distal OFT myocardium may be protective as cardiomyocyte apoptosis in the
early stages (25–30) of OFT remodeling was absent from this region. Furthermore, recombinant adenoviral-mediated expression of dominant
negative Akt, an inhibitor of tyrosine kinase receptor signaling, augmented cardiomyocyte apoptosis in the OFT and constitutively active Akt
suppressed it. Adenovirus-mediated forced expression of VEGF165 induced conotruncal malformation such as double outlet right ventricle
(DORV) and ventricular septal defect (VSD), similar to defects observed when apoptosis-dependent remodeling of the OFT was specifically
targeted. We conclude that normal developmental remodeling of the embryonic avian cardiac OFT involves hypoxia/HIF-1-dependent
signaling and cardiomyocyte apoptosis. Autocrine signaling through VEGF/VEGFR2 and Akt provides survival signals for the hypoxic OFT
cardiomyocytes, and regulated VEGF signaling is required for the normal development of the OFT.
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Introduction the aortic sac, plays a key role in the establishment of theBirds and mammals develop a dual series circulation, in
which deoxygenated blood transits the pulmonary circuit
and oxygenated blood transits the systemic circuit to more
efficiently deliver oxygen to the peripheral tissues. The
transition from a single to dual circulation during develop-
ment is a complex process involving multiple cell types.
The embryonic cardiac outflow tract (OFT), the portion of
the embryonic heart connecting the developing ventricles to0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.05.036
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E-mail address: saf9@po.cwru.edu (S.A. Fisher).dual circulation (reviewed in Pexieder et al., 1995; Rothen-
berg et al., 2003; Webb et al., 2003). In birds and mammals,
OFT myocardium is added from a ‘secondary (anterior)
heart-forming field’ from splanchnic mesoderm beneath the
caudal pharynx after the formation of the primitive heart
tube from the primary heart-forming field. (Kelly et al.,
2001; Mjaatvedt et al., 2001; Waldo et al., 2001). The OFT
subsequently undergoes a complex remodeling process in
the transition to a dual circulation. The OFT is divided into
pulmonary and systemic circuits by septation, a process
dependent upon invasion of cells migrating from the neural
crest (Kirby et al., 1983). The OFT also shortens and rotates
in order for the pulmonary artery to connect to the right
ventricle in a position anterior and to the right of the aorta’s
connection to the left ventricle (De La Cruz et al., 1977;
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ening and rotation of the avian OFT require the spatially and
temporally regulated elimination of OFT cardiomyocytes by
programmed cell death (apoptosis) between stages 25 and
32 (Hamburger and Hamilton, 1951) of chicken develop-
ment (Sallee et al., 2004; Watanabe et al., 1998, 2001). We
have proposed that regional (OFT) myocardial hypoxia is a
trigger for the apoptosis-dependent remodeling of the OFT
based on (1) increased binding of the nitroimidazole EF5,
an indicator of tissue hypoxia (Evans et al., 1997), to the
avian OFT myocardium during the stages of OFT remodel-
ing (25–32); (2) expression of the hypoxia-responsive
vascular endothelial growth factor receptor (VEGFR2) by
the OFT myocardium; (3) approximately coincident migra-
tion of endothelial progenitor cells to the OFT and vasculo-
genesis; and (4) incubation of eggs in hyperoxic air
attenuates the hypoxic stimulus, diminishes the prevalence
of apoptosis, and perturbs OFT remodeling (Sugishita et al.,
2004). However, the specific role of tissue hypoxia in the
remodeling of the embryonic cardiac OFT remains to be
established.
Tissue hypoxia may elicit a broad range of responses,
many of which are dependent upon the hypoxia-inducible
transcription factors (HIFs) (reviewed in Semenza et al.,
1999). The HIFs are heterodimeric transcription factors
consisting of inducible (HIFa-1,2,3) and constitutive
[HIF-1h, also known as arylhydrocarbon receptor nuclear
translocator (ARNT) subunits, each of which contains basic
helix–loop–helix and PAS (Per–Arnt–Sim, named for the
founding members)] domains. The activity of HIF is largely
determined by the induction of the HIF-a subunit in
response to hypoxia. With tissue hypoxia, the oxygen-
dependent proline hydroxylation of HIF-1a is inhibited
(reviewed in Kaelin, 2002; Masson and Ratcliffe, 2003),
allowing nuclear accumulation of HIF1a and transcription
of HIF-dependent target genes. The role of HIFs in devel-
opment has been examined by gene inactivation in mice.
Mice lacking HIF-1a or HIF-1h have early embryonic
lethality (Kotch et al., 1999; Maltepe et al., 1997), suggest-
ing that these transcription factors are essential for the
development of the cardiovascular system. Because of the
early embryonic lethality, the specific role of HIFs in the
subsequent development of the cardiovascular system and,
in particular, in the remodeling of the OFT has not been
addressed. In the current study, we sought to determine (1) if
the expression of the HIF subunits localizes to the devel-
oping cardiac tissues that we have proposed are hypoxic
based on EF5 binding; (2) if HIF expression is oxygen-
sensitive in the developing heart; and (3) the relationship
between hypoxia-dependent gene expression and apoptosis
during heart development, particularly in regards to the
remodeling of the OFT. Our results suggest complexity in
hypoxia/HIF-1 signaling in regulating cardiomyocyte apo-
ptosis in the OFT and the necessity of regulated VEGF/
VEGFR2 signaling for OFT remodeling in the transition to
the dual series circulation of warm blooded animals.Materials and methods
Animals and exposure to hypoxia and hyperoxia
Fertile White Leghorn (Gallus gallus) chicken eggs were
obtained from Squire Valleevue Farm (Cleveland, OH).
Fertile quail (Cortunix Cartunex Japonica) eggs were
obtained from G.Q.F. Manufacturing Co. (Savannah, GA).
Eggs were incubated in a humidified room air incubator at
38jC to the appropriate stages for each experiment [generally
Hamburger-Hamilton (HH) stages 18–32 (ED 3–8)] (Ham-
burger and Hamilton, 1951). For exposure to hyperoxia, eggs
were then placed in a sealed chamber (Modular Incubator
Chamber, Billups-Rothenberg, Inc., Del Mar, CA) with
water, and the chamber was set in a humidified incubator
(Circulated Air Incubator Model 1250, G.Q.F. Manufactur-
ing Co.). The sealed chamber was flushed with 95% O2/5%
CO2 for 10 min to completely exchange the air, and the inlet
and outlet tubes were subsequently clamped. The chamber
was flushed with oxygen gas on a daily basis to maintain
hyperoxia. Control eggs were incubated in the same chamber
in room air. For exposure to hypoxia, eggswere incubated in a
Water Jacketed CO2 Incubator (Model 3130, Forma Scien-
tific, Inc., Marietta, OH) in which oxygen concentration was
digitally set and controlled by the infusion of nitrogen gas.
Immunohistochemistry
Embryos were fixed in fresh 4% paraformaldehyde at
4jC for the appropriate time (1–2 h) for each stage and
cryosectioned at 10-A thickness. The primary antibodies
used in this study were polyclonal rabbit anti-HIF-1a anti-
body (provided by Dr. F. Agani) at 1:200 dilution, polyclonal
rabbit anti-HIF-1h antibody used at 6 Ag/ml (kindly provid-
ed by Dr. R. Pollenz), mouse anti-VEGFR2 IgG1 (kindly
provided by Dr. Eichmann) without dilution, rabbit antiac-
tive caspase-3 antibody (R and D Systems, Minneapolis,
MN) at 1:200 dilution, and mouse anti-HA antibody (Roche,
Indianapolis, IN) at 0.2 Ag/ml. Antiactive caspase-3 antibody
and anti-HA antibody were detected with an appropriate
secondary antibody conjugated with Texas Red (Southern
Biotechnology Associates, Inc., Birmingham, AL) or Alexa
Fluor 488 (Molecular Probes, Eugene, OR), respectively.
Anti-HIF-1a antibody, anti-HIF-1h antibody, and anti-
VEGFR2 antibody were detected with goat antirabbit or
antimouse IgG secondary antibody conjugated with biotin
(Vector, Burlingame, CA), and the signal was amplified with
TSA and fluorescein isothiocyanate (FITC) (Perkin Elmer,
Boston, MA) as per the manufacturer’s instructions. Selected
sections stained with anti-HIF-1a antibody were also stained
with phalloidin conjugated with Alexa Fluor 568 (Molecular
Probes) to delineate myocardium, or 4V,6-diamindino-2-phe-
nylindole (DAPI) (Sigma–Aldrich, St. Louis, MO) to stain
the nuclei. Sections were observed with a fluorescent micro-
scope (Leica DM LB, Leica Microsystems, Wetzlar, Ger-
many) and images captured with SPOT RT camera and
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Heights, MI). Apoptosis was detected by LysoTracker Red
(LTR; Molecular Probes) staining as previously described
(Schaefer et al., 2004). All images were modified with
Adobe Photoshop v.7 to optimize the signal. For compar-
isons between samples, sections were stained and images
captured and modified in parallel.
Western blots
Tissues were microdissected from cardiac OFT of chick
embryos at stages 23, 26, 29, and 33 and homogenized in
lysis buffer consisting of 20 mM Tris, 150 mM NaCl, 1%
Triton X-100, 10% (v/v) Sigma Protease inhibitor cocktail at
a final pH of 7.5. Protein concentrations were determined by
the bicinchoninic acid (BCA) (Pierce, Rockford, IL) meth-
od. Nuclear and cytoplasmic fractions were prepared from
whole hearts of stage 25 chick embryos using the Nuclear
Extraction kit (Active Motif, Carlsbad, CA). Samples were
loaded at 10–15 Ag per lane onto a 4–12% gradient
polyacrylamide gel and run for 2.5 h and subsequently
transferred to polyvinylidene difluoride (PVDF) membrane.
The membrane was blocked with 5% nonfat dry milk in
Tris-buffered saline with 1% Tween (TBST) for 1 h. Anti-
HIF-1a primary antibody was applied at a dilution of 1:500
and allowed to incubate at 4jC overnight. Antirabbit IgG
secondary antibody conjugated with peroxidase (Affinity
Bioreagents, Golden, CO) was applied at a dilution of
1:1000 and allowed to incubate for 1 h at room temperature.
Signals were detected with the enhanced chemilumines-
cence detection system (ECL) (Amersham Biosciences,
Piscataway, NJ).
Recombinant replication-defective adenovirus
Recombinant adenoviruses expressing dominant nega-
tive mutant Akt (Ad-dnAkt) or constitutively active Akt
(Ad-caAkt) under the control of the cytomegalovirus
(CMV) promoter/enhancer were kindly provided by Dr.
Kenneth Walsh (Boston University). An HA tag is fused
in frame to the N termini of the Akt coding sequences in
both of the adenoviruses. The Ad-dnAkt virus expresses the
mutant Akt [K179A, T308A, S473A] that cannot be acti-
vated by phosphorylation, and the Ad-caAkt construct has
the c-Src myristoylation sequence fused in frame to the N
terminus of the HA-Akt (wild-type) coding sequence (Fujio
and Walsh, 1999). A recombinant adenovirus expressing
human VEGF165 under the control of the CMV promoter/
enhancer (AdVEGF-A165) was obtained from Pittsburgh
Experimental Gene Therapy Vector Core Facility, Univer-
sity of Pittsburgh. The recombinant adenovirus expres-
sing green fluorescent protein (GFP) under the control of
the CMV promoter/enhancer (AdCMVGFP) was used as a
control. Recombinant adenoviruses were amplified in
293 cells, purified and titered as previously described
(Fisher and Watanabe, 1996). Titers were approximately1014 (Ad-dnAkt and Ad-caAkt) or 1012 (Ad-VEGF and
AdCMVGFP) pfu/ml. Each recombinant adenovirus was
applied in a volume of 500 nl to the surface of HH stages
18–19 chick or quail embryo hearts as previously described
(Fisher and Watanabe, 1996). After an additional incubation
appropriate for each experiment, the embryos were har-
vested for analyses.Results
Hypoxia-inducible factor in the embryonic chick heart
We first examined expression of HIF-1a in the OFT
myocardium of the stage 30 (ED 7) embryonic chick heart,
the stage at which EF5 binding (hypoxia) and cardiomyo-
cyte apoptosis are maximal (Sugishita et al., 2004; Wata-
nabe et al., 1998). HIF-1a protein was detected in the
proximal and distal region of the OFT myocardium of the
stage 30 chick (n = 3) (Fig. 1A). Costaining with HIF-1a
and phalloidin–Alexa Fluor 568, which binds to filamen-
tous actin and thus identifies cardiomyocytes, showed
colocalization, indicating that HIF-1a was within the myo-
cardial compartment of the OFT (Fig. 1B). HIF-1a was also
detected in the adjacent OFT endocardial cushion mesen-
chymal cells. No signal was detected when the primary
antibody was omitted (n = 2) (Fig. 1C) or when the anti-
HIF-1a antibody was preincubated with competing peptide
(n = 2) (data not shown). Costaining with DAPI (blue, Fig.
1E) and overlaying of images showed that the HIF-1a
localized to the nuclei (Fig. 1F, light blue nuclei). Thus,
HIF-1a is present in the nuclei of cardiomyocytes and
mesenchymal cells of the stage 30 OFT, the stage when
OFT myocardial EF5 binding (hypoxia) is most intense
(Sugishita et al., 2004).
We next examined the stage dependence of HIF-1a
expression. HIF-1a was not detected in the heart at stage
22, just before the apoptosis-dependent remodeling of the
OFT (data not shown). Nuclear accumulation of HIF-1a
was detected at stage 25 throughout the OFT myocardium
(Fig. 2A), as well as at stages 27, 30, and 32 (n = 2 for each
stage) (Figs. 2B–D), encompassing the period when OFT
myocardium is EF5-positive and apoptosis-dependent OFT
remodeling occurs (stages 25–32, ED5–8) (Sugishita et al.,
2004; Watanabe et al., 1998). HIF-1a was not detected
ubiquitously in the nuclei of the ventricular and atrial
myocardium (not shown) but was detected in a few specific
sites at specific stages of development. HIF-1a-positive
nuclei were present in the atrial myocardium adjacent to
the OFT in what is referred to as the inner curvature of the
heart (Fig. 2A). At stage 30, HIF1a-positive nuclei were
detected along the outer edge of the ventricular free wall
near the apex adjacent to the epicardium (n = 3) (Figs. 3A–
C). HIF-1a-positive nuclei were also evident in the myo-
cardium of the right ventricle immediately adjacent to the
OFT of the stage 32 embryo (Fig. 2D). Thus, HIF-1a
Fig. 1. HIF-1a in the stage 30 chick embryo OFT. HIF-1a protein was detected with an anti-HIF-1a antibody and TSA amplification of the fluorescein
isothiocyanate (FITC) signal (Perkin Elmer) as described in Materials and methods. HIF-1a was detected throughout the proximal and distal regions of OFT
myocardium (A, arrows). (B) Costaining for HIF-1a (green) and phalloidin–Alexa Fluor 568 (red), which binds f-actin and delineates the myocardium. HIF-
1a (green) colocalized with the phalloidin staining of the myocardium (red) in the OFT (arrow) and is also present in the adjacent endocardial cushion
mesenchyme. (C) No signal is present when the primary antibody for HIF-1a is omitted. (D, E, F) Region indicated by the rectangle in Panel A at higher
magnification showing HIF-1a staining (D), 4V,6-diamindino-2-phenylindole (DAPI) staining of nuclei (E), and the overlay of images (F) to show nuclear
localization of HIF-1a (light blue nuclei). Images in this and subsequent figures were captured with Spot RT digital camera and modified with Adobe
Photoshop software to optimize the signal. Images within a figure were processed in parallel and captured at identical exposures. Bars, 200 Am in A–C, 50 Am
in D–F.
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correlating with the relative tissue oxygen concentrations as
assessed by EF5 binding.
In contrast to the regulated expression of HIF-1a, HIF-
1h was detected throughout the stages 25 and 30 embryonic
chick heart (Figs. 4A–D). We confirmed that the HIF-1h
was localized to nuclei by costaining with DAPI (data notFig. 2. HIF-1a in the OFT during remodeling (stages 25 – 32).
Immunohistochemistry for HIF-1a was performed in stages 25 (ED 5) to
32 (ED 8) chick embryos, the period when OFT myocardium is hypoxic
and cardiomyocyte apoptosis occurs. (A) HIF-1a was present in OFT
myocardium at stage 25, the stage when the EF5 signal indicating hypoxia
is faintly detected (Sugishita et al., 2004) and is especially intense in the
inner curvature of the OFT. HIF-1a continued to be nuclear-localized in the
OFT myocardium at stages 27 (ED 6), 30 (ED 7), and 32 (ED 8) (B–D).
Bars, 200 Am.shown). Thus, the nuclear accumulation of HIF-1h protein
appears to be constitutive, as it does not localize to the
hypoxic regions of the embryonic chick heart.
Effects of altering ambient oxygen concentrations on
HIF-1a expression
We next determined if the expression of HIF-1a in the
embryonic heart was sensitive to oxygen concentrations by
exposing the embryos within the intact egg to hypoxic or
hyperoxic air using protocols that we previously showed to
result in increased or decreased EF5 binding, respectively
(Sugishita et al., 2004). Incubation of stage 24 eggs in 7.5%
O2 for 7 h induced nuclear accumulation of HIF-1a in
myocardial and endocardial cells throughout the heart (n =
2) (Figs. 5A–D). Incubation of stage 25 embryos in 95%
O2/5% CO2 for 1 day abolished the HIF-1a nuclear accu-
mulation observed in OFT myocardium of stage-matched
embryos incubated under normoxic conditions (n = 2) (Figs.Fig. 3. HIF-1a in the stage 30 chick ventricle. (A) HIF-1a protein was
detected in the outermost region of the ventricular free wall adjacent to the
epicardium. (B, C) Magnified picture of the region within the rectangle in
(A), and showing HIF-1a (B).
Fig. 4. HIF-1h in the embryonic chick heart. HIF-1h protein was detected
with an anti-HIF-1h antibody and TSA amplification of the FITC signal as
described in Materials and methods. HIF-1h was in detected cells of the
OFT (A, C), ventricles (B, D), and atria (not shown) of stages 25 (A, B) and
30 (C, D) embryonic chick heart. HIF-1h localized to the nuclei by DAPI
costaining (not shown). Bars, 50 Am.
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OFT myocardium is associated with tissue hypoxia and
modulated by ambient oxygen concentrations.Fig. 5. HIF-1a responds to changes in ambient oxygen concentrations. HIF-
1a in a stage 24 chick embryo incubated in (A, C) normoxic (21% O2) and
(B, D) hypoxic air (7.5% O2 for 7 h). Nuclear accumulation of HIF-1a was
undetectable in stage 24 control OFT and ventricle and was induced by
hypoxia in cells of the OFT and ventricle. (E) HIF-1a is present in the stage
27 OFT myocardium and (F) is suppressed by incubation in hyperoxic air
(95% O2/5% CO2 for 24 h). In F, the autofluorescence of red blood cells is
seen within the lumen of the ventricle and OFT. Bars, 100 Am.These results were corroborated by analysis of protein
expression by Western blotting. A 120-kDa band
corresponding to HIF-1a protein was detected in stages
26–33 OFT homogenates (Fig. 6). HIF-1a was detected in
the nuclear and not the cytoplasmic fraction of embryonic
heart extracts and significantly up-regulated by hypoxia.
Relationship of HIF-1a expression to OFT cardiomyocyte
apoptosis
As a first step in defining the relationship between HIF-
1a expression and OFT cardiomyocyte apoptosis, we deter-
mined if they colocalized during heart development. We
used the anti-HIF-1a antibody and LysoTracker Red (LTR),
or the antiactive caspase-3 antibody, to colocalize apoptosis
and HIF-1a in the hearts of stages 29–32 chick embryos.
HIF-1a was detected in nuclei throughout the OFT myo-
cardium of the stage 29 embryo. There was particularly
strong staining for HIF-1a in the dorsal portion of the OFT
in the region referred to as the inner curvature. Apoptotic
cardiomyocytes in the stage 29 embryo, detected by either
LTR (Fig. 7) or antiactive caspase-3 antibody (data not
shown), were concentrated in the proximal OFT myocardi-
um (n = 2), as we have shown previously (Schaefer et al.,
2004; Watanabe et al., 1998). Few or no apoptotic cardio-
myocytes were detected in the distal OFT myocardium or
the dorsal region of the OFT of the stage 29 embryo. Thus,
there is overlap of nuclear HIF-1a and cardiomyocyte
apoptosis in the proximal OFT, while nuclear HIF-1a is
also detected in the distal and dorsal OFT myocardium,
where there is minimal apoptosis at the earlier stages of OFT
remodeling (25–30).
To more directly test the role of hypoxic induction of
HIF-1a in cardiomyocyte apoptosis, intact stage 24 eggs
were incubated under hypoxic conditions (7.5% oxygen for
5 h) that induced HIF-1a nuclear accumulation in the heart.
These embryos examined in whole mount showed increased
LTR staining in the OFT but not in the remainder of the
heart (n = 5 experimental, n = 4 control embryos; Figs. 8A,
B). In sections, it was apparent that this increased LTRFig. 6. Detection of HIF-1a protein by Western blot. Nuclear extract from
deferoxamine mesylate-treated Hepa cells (positive control, Con), homo-
genates of embryonic chick OFTs from stages 23, 26, 29, and 33, and
nuclear and cytoplasmic extracts of stage 25 chick hearts incubated in
normoxia (21% O2) or hypoxia (7.5% O2, 7 h) were collected and analyzed
by Western blotting as described in Materials and methods. Ten micrograms
of protein was loaded from each sample. Specific bands for HIF-1a were
detected at 120 kDa. Additional bands were not observed. HIF-1a is
expressed most intensely in the stages 26 and 29 OFT, localizes to the
nuclear fraction, and is induced by hypoxia.
Fig. 7. Costaining for HIF-1a and LysoTracker Red (LTR), a marker of
apoptosis, in the stage 29 chick embryo. HIF-1a was detected in both
proximal and distal regions of the OFT myocardium and in both the ventral
and dorsal OFT myocardium. LTR, which accumulates in the lysosomes of
dying cardiomyocytes (Schaefer et al., 2004), was abundant only in the
proximal-ventral OFT myocardium at this stage, as we previously reported
(Schaefer et al., 2004). Similar results were obtained at earlier stages of
development (not shown). Bars, 200 Am.
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the myocardium (Figs. 8C, D). In addition, the LTR signal
was not above background in the ventricular myocardium of
hypoxic embryos (Fig. 8B), although HIF-1a accumulated
in the nuclei of the ventricular myocytes under these
conditions. Therefore, hypoxia or HIF-1a nuclear accumu-
lation by itself is insufficient for inducing cardiomyocyte
apoptosis in the developing embryo. We also used other
hypoxia exposure protocols, including a variety of hypoxia/
normoxia regimens for up to 24 h, but in no instance did we
observe significant increases in apoptosis in the OFT or
ventricular myocardium. Short exposures to more intense
hypoxia, for example, 3 h at 5% oxygen, resulted in necroticFig. 8. Effect of ambient hypoxia on cardiomyocyte apoptosis in the OFT. Chick e
(7.5% O2 for 5 h) air and stained with LTR. The number of LTR particles obser
hypoxia as compared with (A) normoxia. In section, it is evident that the increased
of the OFT (compare D with C). There was no significant difference between thdeath of the myocardium and nonviable embryos (data not
shown).
VEGFR2 and cardiomyocyte apoptosis
Hypoxia signaling through HIF-1a may have pro- or
antiapoptotic effects depending on the context (reviewed in
Wenger, 2002, and Discussion). We previously showed that
VEGFR2 is expressed in cardiomyocytes in the distal OFT
myocardium of the stage 30 embryo and that the expression
is oxygen-sensitive (Sugishita et al., 2004). This raised the
possibility that expression of VEGFR2 in the OFT myocar-
dium is a hypoxia-dependent cytoprotective response. As a
first step in defining the relationship between VEGFR2
expression and OFT cardiomyocyte apoptosis, we examined
their dynamic patterns of expression during heart develop-
ment. At stage 25, VEGFR2 protein was weakly detected in
the OFT myocardium and was abundant in the endocardi-
um/endothelium and in the distal OFT at the site of
formation of the aorticopulmonic septum (Fig. 9A). The
intensity of VEGFR2 signal in the OFT myocardium
increased at subsequent stages and was most intense in the
myocardium of the distal OFT (Figs. 9B–D). The signal
was maximal at stage 30 and diminished at stage 32 (Figs.
9C, D). At stages 30 and 32, the signal for VEGFR2 was
also detected in the epicardium at the site of vessel forma-
tion (Figs. 9C, D; arrowheads) and within the endocardial
cushions as they are shaped into valves.
We next colocalized VEGFR2 expression with markers
of apoptosis to determine if there may be a relationship
between the two. At stages 29 and 30, VEGFR2 wasmbryos at stages 24–25 were incubated in normoxic (21% O2) or hypoxic
ved in whole mount is increased in the OFT in embryos incubated in (B)
LTR in the embryos incubated in hypoxic air is in the cushion mesenchyme
e two groups in LTR in the OFT myocardium (C, D). Bars, 200 Am.
Fig. 9. Stage dependence of VEGFR2 expression in the chick OFT.
VEGFR2 expression was examined in stages (A) 25, (B) 27, (C) 30, and
(D) 32 chicken embryos. The intensity of VEGFR2 staining in the OFT
myocardium had a stage dependence similar to that of EF5 binding
(hypoxia) (Sugishita et al., 2004). It was first detected at stage 25,
maximal at stage 30 and diminished by stage 32, and most prominent in
the distal OFT myocardium. At stage 25, VEGFR2 was also present in the
forming aorticopulmonic septum (A, arrowheads). At stages 30 and 32,
VEGFR2 was also detected in endothelial cells within the epicardium at
the apparent sites of vessel formation and on the downstream surface of
the stage 32 forming valve leaflets (C, D, arrowheads). At all stages,
VEGFR2 was detected in the endothelium lining the heart and great
vessels. Bars, 500 Am.
Fig. 10. Costaining for VEGFR2 and LysoTracker Red in the OFT.
Localization of VEGFR2 and cardiomyocyte apoptosis in OFT myocar-
dium was examined in stages (A) 29, (B) 30, (C) 31, and (D) 32 chick
embryos. (A, B) At stages 29 and 30, VEGFR2-positive myocardium was
found mainly in the distal region of OFT myocardium (arrows), while
LysoTracker Red (LTR) signals, a marker of apoptotic cardiomyocytes,
were localized in the proximal region of OFT myocardium (arrowheads).
At stage 31, LTR signals were observed along the entire length of the OFT
myocardium (arrowheads) and overlapped with the distal region of OFT
expressing VEGFR2 expression. At stage 32, OFT myocardium shortened,
and VEGFR2 and LTR signals were diminished (D). Bars, 200 Am.
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um, while LTR was predominantly in the proximal region of
the OFT myocardium (Figs. 10A, B; arrowheads). Two days
later, at stage 31, LTR signals were detected throughout the
OFT myocardium, including the distal region (Fig. 10C;
arrowheads), where VEGFR2 expression was observed. At
stage 32, the OFT myocardium had shortened, and
VEGFR2 signals and LTR staining, while still present, were
markedly diminished (Fig. 10D). The same results were
observed by costaining with anti-VEGFR2 and antiactive
caspase-3 antibodies (data not shown). Thus, in the early
stages of OFT remodeling (25–30), cardiomyocyte apopto-
sis is excluded from the distal region of the OFT where
VEGFR2 expression is maximal. Subsequently, after several
more days of development, the more distal OFT cardio-
myocytes also succumb to a death-inducing stimulus, while
the surviving OFT cardiomyocytes form the subpulmonic
infundibulum (Watanabe et al., 1998).
The PI3K/Akt pathway mediates the cell-protective ef-
fect of VEGF/VEGFR signaling (reviewed in Wick et al.,
2002). To test the role of VEGF receptor/tyrosine kinase
signaling in survival of OFT cardiomyocytes, stages 18–19
embryonic hearts were transduced in ovo with recombinant
replication-defective adenovirus expressing dominant nega-
tive (AddnAkt) or constitutively active (AdcaAkt) Akt
(Fujio and Walsh, 1999). Staining for the HA tag showed
that mutant Akt was selectively expressed in the OFTmyocardium (Fig. 11A), as we have previously shown for
the expression of other transgenes in this model (Fisher and
Watanabe, 1996; Watanabe et al., 1998). No difference in
the frequency of apoptosis was observed between control
and AddnAkt or AdcaAkt transduced hearts 1–2 days after
incubation (stages 22–25, n = 12 AdAkt, n = 6 control
embryos, not shown). Three days after adenovirus delivery
(stages 28–30), there were significantly more LTR particles
throughout the OFT of the Ad-dnAkt embryos as compared
to control embryos (n = 7 Ad-dnAkt vs. n = 4 control, Figs.
11B, C). Examination of these hearts in section revealed that
the increased apoptosis was confined to the OFT myocar-
dium (data not shown). Three days after the delivery of the
Ad-caAkt adenovirus (stages 28–30), there were signifi-
cantly fewer LTR particles in the OFT as compared to
control embryos (n = 4 each, Fig. 11D). Thus, forced
expression of dominant negative or constitutively active
Akt protein specifically affects OFT cardiomyocyte apopto-
sis during the stages of hypoxia-dependent apoptotic remod-
eling of the OFT, suggesting that VEGF signaling through
VEGFR2 and Akt may provide a survival signal to the OFT
cardiomyocytes (see Discussion).
Forced expression of VEGF165 causes OFT defects
To further test the role of hypoxia-regulated gene
expression in OFT remodeling, we used recombinant ade-
novirus to force the expression of the VEGF ligand
(VEGF-A165 isoform). We used quail embryos for these
Fig. 11. Effect of dominant negative and constitutively active Akt on OFT
cardiomyocyte apoptosis. Stage 18 chick embryos were infected with
recombinant replication-defective adenoviruses expressing dominant neg-
ative or constitutively active Akt as described in Materials and methods. (A)
The hemagglutinin tag on the adenoviral-expressed Akt is detected by
immunohistochemistry exclusively in the OFT of the stage 27 chick
embryo. We have previously shown that this method of transgene delivery
targets expression to the OFT myocardium. (B–D) Prevalence of apoptosis
was detected by LTR staining and observed in intact (whole mount) hearts.
(B) A control stage 30 chick embryo shows apoptosis concentrated at the
base of the OFT (arrow). (C) A stage 30 chick embryo heart transduced
with adenovirus expressing dominant negative mutant Akt. The number of
LTR particles was significantly increased throughout the OFT (arrow) as
compared with control embryos (D) A stage 30 chick embryo transduced
with adenovirus expressing constitutively active Akt. The number of LTR
particles was significantly diminished in OFT (arrow) compared with
control embryos. Bars, 200 Am in A, 500 Am in B–D. OFT indicates
outflow tract; RV, right ventricle; LV, left ventricle.
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cally identify endothelial progenitors in quail only (Parda-
naud et al., 1987), and apoptosis-dependent remodeling of
the OFT is similar to that of the chicken (Rothenberg et al.,
2002). Forced expression of VEGF-A165 in the embryonic
quail heart OFT myocardium had no significant effect on
the prevalence of apoptosis during OFT remodeling (data
not shown) but did have a significant effect on OFT
morphogenesis (Fig. 12). In control embryos, the rotation
and shortening of the OFT are nearly complete by stage 31,
so that the pulmonary artery connects to the right ventricle
in a position anterior and slightly rightward of the connec-
tion of the aorta to the left ventricle (Figs. 12A–C). In 9 of
14 embryos transduced with AdVEGF-A165, both aorta
and pulmonary artery connected to right ventricle, showing
double outlet right ventricle (DORV) morphology (Figs.
12D–I). In some instances, there was also a large ventric-
ular septal defect (VSD) (Figs. 12G–I). The OFT cushions
appeared hypercellular, and in some embryos, ventricularthinning was also observed. Thus, hypoxia-dependent
responses that include regulated expression of VEGF and
VEGFR signaling are required for the normal developmen-
tal remodeling of the OFT in the transition to a dual
circulation.Discussion
We previously proposed a model in which myocardial
hypoxia triggers the apoptosis-dependent remodeling of the
avian OFT in the transition to a dual circulation (Sugishita et
al., 2004). In this study, we demonstrate that HIF-1a
specifically accumulates in the nuclei of OFT cardiomyo-
cytes from stages 25–32, the stages of increased EF5
binding and apoptosis-dependent remodeling of the OFT
(Sugishita et al., 2004; Watanabe et al., 1998). HIF-1a
expression and EF5 binding are suppressed by increased
ambient oxygen concentrations, supporting the contention
that these are markers of OFT myocardial hypoxia during
the phase of OFT remodeling (stages 25–32). Nuclear HIF-
1a protein was induced in cells throughout the heart by
incubation at 7.5% oxygen (approximately 57 mm Hg),
further indicating that nuclear accumulation of HIF-1a in
the embryonic heart is a hypoxic response. This concentra-
tion of oxygen is much higher than those that are reported to
induce HIF-1a in cultured cells (reviewed in Semenza et al.,
1999), suggesting that the working embryonic heart may be
more sensitive than are cultured cells to oxygen deprivation.
HIF-1a protein was also detected in tissues where we did
not previously detect increased EF5 binding, such as the
stage 30 endocardial cushion mesenchyme adjacent to the
myocardium and the stage 30 ventricular myocardium at the
apex adjacent to the epicardium. The comparison between
EF5 binding and abundance of HIF-1a is complicated by
the likely differing sensitivity and dynamic range of the
assays depending upon the antibody used and method of
detection. Thus, it is possible that the cells that are HIF-1a-
positive but were not observed to have increased EF5
binding are hypoxic relative to other cells but are less
hypoxic than the OFT myocardium. Using signal amplifi-
cation to detect EF5 binding has revealed regions of
apparent tissue hypoxia in the embryonic heart that was
not evident in our initial analysis (unpublished data). Alter-
natively, it is possible that HIF-1a nuclear accumulation in
some of the cells of the embryonic heart is a response to
other signals, for example, cytokines, which also may
stabilize HIF-1a protein (reviewed in Bruick, 2003;
Wenger, 2002). In contrast to the hypoxia-dependent accu-
mulation of HIF-1a in the embryonic heart, the nuclear-
localization of its dimerization partner HIF-1h (Arnt) was
constitutive. An earlier study suggested that nuclear accu-
mulation of HIF-1h protein is spatially and temporally
restricted during heart development (Walker et al., 1997).
In this study, we used a signal amplification method to
detect HIF-1h (and HIF-1a) which may obscure modest
Fig. 12. The effect forced expression of VEGF-A165 on the development of the heart and OFT. Stage 18 quail embryo hearts were transduced with
recombinant replication-defective adenovirus expressing VEGF-A165 or GFP as a control. Sections were prepared from stage 31 control (AdGFP) and
AdVEGF-A165 hearts. Representative frontal sections, from anterior to posterior, are shown for (A–C) control and (D–I) two different AdVEGF-A165 hearts.
In the control embryos, the aorta and pulmonary artery were connected to left and right ventricles, respectively. The RVOT is anterior to the Ao and tilts to the
left while the LVOT course from left to right. In the embryos with AdVEGF-A165, both the aorta and pulmonary artery connect to the right ventricle [double
outlet right ventricle (DORV)], and the spiral relationship of the two outlets is absent. (G–I) A large VSD is also observed. Some of the AdVEGF-hearts also
have thinning of the ventricular myocardium. Bars, 200 Am. PA indicates pulmonary artery; Ao, aorta; RV, right ventricle; LV, left ventricle; RA, right atrium;
LA, left atrium; VSD, ventricular septal defect.
Y. Sugishita et al. / Developmental Biology 273 (2004) 285–296 293differences in protein expression, although the HIF-1h
subunit in most other systems is constitutively expressed.
How might hypoxia regulate the apoptosis-dependent
remodeling of the embryonic cardiac outflow tract? Hypoxia
signaling through HIF-1-dependent or -independent tran-
scriptional mechanisms may induce the expression of pro-
or antiapoptotic genes, depending on the cell type and
context (Alvarez-Tejado et al., 2001; Dong and Wang,
2004; Dong et al., 2001; Kubasiak et al., 2002; Regula et
al., 2002; Sowter et al., 2001). Supporting the complexity of
the relationship between HIF expression and cell death/
survival in vivo, we found HIF1a expression in regions ofthe OFT myocardium where apoptosis was both prevalent as
well as sparse. In contrast, myocardial expression of
VEGFR2 was restricted to the more distal portion of the
OFT myocardium where during the early stages of OFT
remodeling (stages 25–30, ED5–7) cardiomyocyte apopto-
sis is not prevalent. As the VEGFR2 gene (and VEGF gene)
contains hypoxia-responsive elements and in many instan-
ces are regulated by hypoxia/HIFs (Elvert et al., 2003;
Kappel et al., 1999), this suggests the hypothesis that
hypoxia (HIF)-dependent induction of VEGFR2 in the
OFT myocardium protects the cardiomyocytes from poten-
tial death-inducing signals. An autocrine protective effect of
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other models of hypoxia and ischemia (Alvarez-Tejado et
al., 2001; Jin et al., 2000; Ogunshola et al., 2002; Rissanen
et al., 2002; Wick et al., 2002) reviewed in Shiojima and
Walsh (2002). Using several commercially available anti-
bodies, we were not able to detect activation (phosphoryla-
tion) of endogenous VEGFR2 or of its downstream effector,
the kinase Akt in situ (data not shown). However, we used a
loss-of-function approach and showed that forced expres-
sion of dominant negative Akt (kinase-defective) signifi-
cantly increased apoptosis in the OFT cardiomyocytes. This
response appeared to be specific to the hypoxic challenge as
it was only observed approximately 3 days after viral
transduction (stages 28–30 embryos), the stage of maximal
hypoxic stress in the OFT myocardium. In contrast, in this
system, transgene expression is maximal at 24–48 h after
transduction with recombinant adenovirus (Fisher and Wata-
nabe, 1996), and apoptosis is induced as early as 12–24
h (stages 20–21) after forced expression of a death receptor
(Fas) ligand (Sallee et al., 2004). This suggests that the
delayed apoptotic response to dnAkt is specific to the death-
inducing stimulus, which we propose is hypoxia, between
stages 25 and 32. We also used gain-of-function approach
by expressing constitutively active (myristylated) Akt to
show a reduction in the prevalence of apoptosis in the stages
28–30 OFT cardiomyocytes. These experiments provide
strong evidence that the kinase Akt provides a survival
signal to the OFT cardiomyocytes. Akt signaling is not
specific to VEGFR, and it remains to be shown that Akt is
activated by VEGFR in these cells during normal develop-
ment. A number of targets of Akt survival signaling have
been identified, including the Bcl-2 family member Bad,
Ask (apoptosis signal regulating kinase), and Flip (Fas
ligand inhibitory peptide) (reviewed in Lawlor and Alessi,
2001), and it will be of interest to examine these potential
targets in the developing OFT.
Does hypoxia induce the programmed cell death of OFT
cardiomyocytes during normal development? The coinci-
dence of EF5 binding, an indicator of tissue hypoxia, and
stage-dependent apoptosis is suggestive of a relationship
between the two. There also is overlap between the expres-
sion of HIF-1a in the proximal OFT myocardium and
apoptosis, further suggesting a relationship between hypoxia
and apoptosis. However, a hypoxic stimulus that was
sufficient to induce nuclear accumulation of HIF-1a
throughout the heart did not result in apoptosis in either
the OFT myocardium or cardiomyocytes in other chambers
of the heart. These results could be interpreted as showing
that tissue hypoxia (and nuclear accumulation of HIF-1a)
by itself is not sufficient to induce apoptosis of cardiomyo-
cytes. This would be akin to in vivo studies of the adult
myocardium where hypoxia (ischemia) plus reperfusion are
more effective at inducing apoptosis than hypoxia (ische-
mia) alone (reviewed in Gottlieb, 2003; Regula et al., 2003).
Similarly with in vitro studies of isolated cardiomyocytes,
hypoxia plus acidosis or metabolic inhibition are required toinduce apoptosis (Bishopric et al., 2001; Dong and Wang,
2004; Webster et al., 1999). One important distinction
between this study and the in vitro experiments is in the
degree of hypoxia. In vitro experiments are done at near
anoxic conditions (less than 1% oxygen) for prolonged
periods (24–48 h). In the working embryonic heart, in
ovo exposure to 5% oxygen for 3 h resulted in myocardial
necrosis and cessation of the circulation. It is thus problem-
atic to extrapolate from in vitro to in vivo studies, although
it is possible that different results would be obtained with
regional myocardial hypoxia as opposed to the global
hypoxia of the working heart in ovo used in this study.
It is possible that the hypoxic stimulus is required at the
specific stage in development during which it normally
occurs and that it is the response to the stimulus at these
specific stages (25–32) that triggers apoptosis-dependent
remodeling of the OFT. In this scenario, precocious expo-
sure to hypoxia would not induce apoptosis. One such
response to tissue hypoxia could be the recruitment of
endothelial progenitors cells to the OFT and vasculogenesis
(‘‘developmental reperfusion’’), a process that is coincident
with apoptosis-dependent remodeling of the OFT (Rothen-
berg et al., 2002; Sugishita et al., 2004). Support for this
scenario is provided by our previous experiments which
showed that delaying the epicardial coverage of the OFT
myocardium, thereby inhibiting proendothelial cell invasion
of the OFT myocardium, significantly reduced the preva-
lence of apoptosis (Rothenberg et al., 2002). Other studies
have shown that hypoxia/ischemia up-regulates the expres-
sion of death ligands/factors in cardiomyocytes(Tanaka et
al., 1994) and endothelial cells (Scarabelli et al., 2001); in
this scenario, the invading endothelial progenitor cells
would trigger OFT cardiomyocyte apoptosis through the
death receptor pathway. We have not yet identified an
endogenous death ligand in the OFT but have shown that
forced expression of a death ligand is a potent killer of
embryonic cardiomyocytes in ovo (Sallee et al., 2004).
Hypoxia/HIF-1 may also induce the transcription of proa-
poptotic Bcl-2 family members such as BNIP3, Nix, and
Noxa in cardiomyocytes and nonmuscle cells (Bruick, 2000;
Kim et al., 2004; Kubasiak et al., 2002; Lee et al., 2004;
Regula et al., 2002; Yussman et al., 2002) that trigger cell
death through the mitochondrial pathway. The pattern of
expression of these proteins in relation to developmental
apoptosis remains to be investigated.
Our previous study showed that prolonged exposure to
hyperoxia results in morphologic defects of the OFT
(Sugishita et al., 2004) that phenocopy the effects of
inhibitors of apoptosis (Watanabe et al., 2001). This sug-
gests that perturbations in the remodeling of the OFT in the
transition to a dual circulation may involve oxygen-sensitive
mechanisms. In the current study, we showed that forced
expression of a hypoxia-responsive gene, VEGF-A165,
caused similar conal defects, DORV with large VSD, as
well as ventricular thinning. These defects are similar to
those previously reported in chick embryos injected with
Y. Sugishita et al. / Developmental Biology 273 (2004) 285–296 295VEGF protein (Feucht et al., 1997) or mice that overexpress
VEGF (Miquerol et al., 2000; Stalmans et al., 2003). In the
current study, an effect of VEGF165 on OFT cardiomyocyte
apoptosis was not observed, and the cell or molecular
mechanism by which overexpression of VEGF leads to
OFT defects remains to be determined. VEGF has also been
proposed to stimulate the proliferation of endocardial cush-
ion cells and inhibit their transformation to a mesenchymal
phenotype (Dor et al., 2001, 2003) which could also
contribute to the observed phenotype.
In conclusion, hypoxia-dependent responses are critical
to the normal developmental remodeling of the OFT in the
transition of the avian embryo to a dual circulation. The
survival of OFT cardiomyocytes that eventually form the
subpulmonic infundibulum involves expression of VEGFR2
and Akt signaling. Whether hypoxia and HIF-1 induce OFT
cardiomyocyte apoptosis through transcriptional responses
and a death receptor and/or mitochondrial pathway requires
further study. It will also be of interest to determine if tissue
hypoxia during the remodeling of the OFT myocardium
renders this tissue susceptible to toxic effects of teratogens
that are associated with congenital human conotruncal heart
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